Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved..

Anticoagulation with unfractionated heparin is vital to reduce the risk of thromboembolic events during cardiopulmonary bypass and left ventricular assist device placement. However patients with heparin-induced thrombocytopenia are at risk of developing immune-mediated thrombotic events. We describe 2 patients with heparin-induced thrombocytopenia confirmed via serotonin release assay who were successfully treated with plasmapheresis exchange before left ventricular assist device placement.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:109

Enthalten in:

The Annals of thoracic surgery - 109(2020), 6 vom: 15. Juni, Seite e439-e440

Sprache:

Englisch

Beteiligte Personen:

Maffei, Salvador R [VerfasserIn]
Lamba, Harveen K [VerfasserIn]
Mensah, Cassius Kwasi [VerfasserIn]
Bracey, Arthur [VerfasserIn]
Civitello, Andrew [VerfasserIn]
Delgado, Reynolds [VerfasserIn]
Simpson, Leo [VerfasserIn]
Nair, Ajith [VerfasserIn]
Frazier, O H [VerfasserIn]
Morgan, Jeffrey A [VerfasserIn]

Links:

Volltext

Themen:

9005-49-6
Anticoagulants
Case Reports
Heparin

Anmerkungen:

Date Completed 03.08.2020

Date Revised 03.08.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.athoracsur.2019.09.056

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM303187530